V. Poulaki

1.6k total citations
34 papers, 1.3k citations indexed

About

V. Poulaki is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, V. Poulaki has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Ophthalmology and 8 papers in Oncology. Recurrent topics in V. Poulaki's work include Cell death mechanisms and regulation (7 papers), Retinal Diseases and Treatments (6 papers) and Cancer-related Molecular Pathways (6 papers). V. Poulaki is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Retinal Diseases and Treatments (6 papers) and Cancer-related Molecular Pathways (6 papers). V. Poulaki collaborates with scholars based in United States, Germany and United Kingdom. V. Poulaki's co-authors include Nicholas Mitsiades, Maria Tsokos, Ivan Stamenkovic, Wei‐Hsuan Yu, Anthony P. Adamis, C Mitsiades, Demetrios A. Koutras, Tara Moore, Yuichi Kaji and Jonathan E. Moore and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and The FASEB Journal.

In The Last Decade

V. Poulaki

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Poulaki United States 17 735 300 291 277 197 34 1.3k
William Benedict United States 6 912 1.2× 267 0.9× 295 1.0× 666 2.4× 159 0.8× 9 1.7k
Frederick Pfister Germany 21 593 0.8× 102 0.3× 101 0.3× 497 1.8× 167 0.8× 43 1.8k
Denise A. Hatala United States 13 488 0.7× 120 0.4× 164 0.6× 327 1.2× 194 1.0× 16 1.1k
Lauri Miller United States 12 998 1.4× 444 1.5× 387 1.3× 600 2.2× 273 1.4× 16 2.1k
Guo‐Rui Dou China 23 716 1.0× 68 0.2× 256 0.9× 304 1.1× 157 0.8× 50 1.3k
Tye Deering United States 22 850 1.2× 238 0.8× 85 0.3× 214 0.8× 143 0.7× 34 1.5k
Shu‐Ching Shih United States 18 943 1.3× 178 0.6× 364 1.3× 98 0.4× 295 1.5× 22 1.6k
Paul McGuire United States 18 580 0.8× 79 0.3× 180 0.6× 1.1k 3.9× 116 0.6× 27 1.6k
Olga A. Agapova United States 23 914 1.2× 232 0.8× 145 0.5× 893 3.2× 155 0.8× 29 1.8k
Yoshinobu Toda Japan 26 1.2k 1.6× 496 1.7× 440 1.5× 112 0.4× 160 0.8× 50 2.0k

Countries citing papers authored by V. Poulaki

Since Specialization
Citations

This map shows the geographic impact of V. Poulaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Poulaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Poulaki more than expected).

Fields of papers citing papers by V. Poulaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Poulaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Poulaki. The network helps show where V. Poulaki may publish in the future.

Co-authorship network of co-authors of V. Poulaki

This figure shows the co-authorship network connecting the top 25 collaborators of V. Poulaki. A scholar is included among the top collaborators of V. Poulaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Poulaki. V. Poulaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabral, Howard, Nicole H. Siegel, Xuejing Chen, et al.. (2024). Associations Between Retinal Vascular Occlusions and Dementia. Healthcare. 12(23). 2371–2371. 2 indexed citations
2.
Ness, Steven, Michael Green, Alexander Port, et al.. (2021). Risk factors for fellow eye treatment in protocol T. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(8). 2203–2212. 2 indexed citations
3.
Poulaki, V., Seong-Joon Kim, William D. Eldred, et al.. (2020). Implantation and Extraction of Penetrating Electrode Arrays in Minipig Retinas. Translational Vision Science & Technology. 9(5). 19–19. 8 indexed citations
4.
Poulaki, V., et al.. (2015). Teleretinal Imaging for Detection of Referable Macular Degeneration. Optometry and Vision Science. 92(6). 714–718. 9 indexed citations
5.
Poulaki, V. & Shizuo Mukai. (2008). Retinoblastoma: Genetics and Pathology. International Ophthalmology Clinics. 49(1). 155–164. 10 indexed citations
6.
Poulaki, V., Nicholas Mitsiades, Eirini Iliaki, et al.. (2007). TIMP3 Inhibits Vascular Leakage and Leukostasis in an Animal Model of Streptozotocin-Induced Diabetes. Investigative Ophthalmology & Visual Science. 48(13). 1383–1383. 1 indexed citations
7.
Kociok, Norbert, et al.. (2006). Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Graefe s Archive for Clinical and Experimental Ophthalmology. 245(2). 258–266. 1 indexed citations
8.
Poulaki, V., et al.. (2004). Intensive insulin therapy–induced vascular leakage and leukostasis in diabetes are decreased by anti–IGF. Investigative Ophthalmology & Visual Science. 45(13). 4111–4111. 1 indexed citations
9.
Poulaki, V., et al.. (2003). Reduced Histopathological Alterations in Long-Term Diabetic TNF-R Deficient Mice. Investigative Ophthalmology & Visual Science. 44(13). 3894–3894. 3 indexed citations
10.
Poulaki, V., et al.. (2002). Non-steroid Alanti-inflammatory Drugs Prevent Early Diabetic Retinopathy: Aspirinand COX-2 Inhibition Prevent Blood-retinal Barrier Breakdown and Leukocyte Adhesion Via TNF-asuppression. Investigative Ophthalmology & Visual Science. 43(13). 2969–2969. 2 indexed citations
11.
Frizzell, Norma, et al.. (2002). A Modulatory Role for Advanced Glycation End-Products (AGEs) in Retinal Microvascular Leukostasis. Investigative Ophthalmology & Visual Science. 43(13). 1348–1348. 3 indexed citations
12.
Poulaki, V., Tamim Qaum, Qin Xu, et al.. (2002). Suppression of Diabetic Retinopathy with Angiopoietin-1. Investigative Ophthalmology & Visual Science. 43(13). 2965–2965. 2 indexed citations
13.
Poulaki, V., et al.. (2002). The TNF-Inhibitor Enbrel prevents early diabetic retinal changes in vivo. Investigative Ophthalmology & Visual Science. 43(13). 1332–1332. 1 indexed citations
14.
Mitsiades, Nicholas, Wei‐Hsuan Yu, V. Poulaki, Maria Tsokos, & Ivan Stamenkovic. (2001). Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.. PubMed. 61(2). 577–81. 302 indexed citations
15.
Joussen, Antonia M., et al.. (2001). Inhibition of inflammatory corneal angiogenesis by TNP-470.. PubMed. 42(11). 2510–6. 40 indexed citations
16.
Mitsiades, Nicholas, et al.. (2001). Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends in Endocrinology and Metabolism. 12(9). 384–390. 48 indexed citations
17.
Leone, Alvaro, Nicholas Mitsiades, Yvona Ward, et al.. (2001). The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma. Oncogene. 20(25). 3217–3225. 38 indexed citations
18.
Mitsiades, Nicholas, Constantine S. Mitsiades, V. Poulaki, Kenneth C. Anderson, & Steven P. Treon. (2001). Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias. Expert Opinion on Investigational Drugs. 10(8). 1521–1530. 33 indexed citations
19.
Poulaki, V., et al.. (1999). p53 expression and regulation by NMDA receptors in the developing rat brain. Journal of Neuroscience Research. 56(4). 427–440. 20 indexed citations
20.
Mitsiades, Nicholas, V. Poulaki, Alvaro Leone, & Maria Tsokos. (1999). Fas-Mediated Apoptosis in Ewing's Sarcoma Cell Lines by Metalloproteinase Inhibitors. JNCI Journal of the National Cancer Institute. 91(19). 1678–1684. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026